Paper Details

  1. Home
  2. Paper Details

An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers.

Author: AbdelmoatyMai M, GendelmanHoward E, LuYaman, MosleyR Lee, NammingaKrista L, ObaroHelen, OlsonKatherine E, SantamariaPamela

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Sargramostim has been reported to be clinically useful and safe for cancer, acute radiation syndrome, autoimmune disease, inflammatory conditions, and Alzheimer's disease. The safety, tolerability, and mechanisms of action in Parkinson's disease (PD) during extended use have not been evaluated.
Paper Details　
Original Abstract of the Article :
The clinical utility and safety of sargramostim has previously been reported in cancer, acute radiation syndrome, autoimmune disease, inflammatory conditions, and Alzheimer's disease. The safety, tolerability, and mechanisms of action in Parkinson's disease (PD) during extended use has not been eval...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201023/

データ提供：米国国立医学図書館（NLM）

Sargramostim: A Potential Treatment for Parkinson's Disease?

The world of [neurology] is constantly seeking new treatments for [Parkinson's disease]. This study explores the safety and tolerability of [sargramostim] in treating [Parkinson's disease] over an extended period. The researchers found that [sargramostim] was generally well-tolerated and did not cause any significant adverse effects. This finding suggests that [sargramostim] could potentially be a safe and effective treatment option for [Parkinson's disease], although further research is needed to confirm its efficacy.

Exploring the Potential of Sargramostim for Parkinson's Disease

This study provides valuable insights into the safety and tolerability of [sargramostim] in treating [Parkinson's disease]. While the study did not definitively prove its efficacy, it lays the groundwork for future research to explore the potential benefits of this medication. The findings suggest that [sargramostim] could potentially be a safe and effective treatment option for [Parkinson's disease], offering hope for patients seeking relief from this debilitating condition.

A Promising Avenue for Parkinson's Disease Treatment

Think of [Parkinson's disease] as a stubborn desert sandstorm, relentlessly eroding the pathways of the brain. [Sargramostim] acts like a sturdy camel caravan, offering a path through the storm and potentially helping to restore order and function. This study provides evidence that [sargramostim] might be a valuable tool in the fight against [Parkinson's disease], though further research is needed to fully understand its potential benefits.

Dr.Camel's Conclusion

This study provides promising evidence that [sargramostim] could be a safe and potentially effective treatment option for [Parkinson's disease]. While further research is needed to confirm its efficacy, this study offers hope for patients struggling with this debilitating condition. The researchers' findings suggest that [sargramostim] could potentially play a significant role in managing and treating [Parkinson's disease] in the future.

Date :
  1. Date Completed 2023-05-24
  2. Date Revised 2023-06-24
Further Info :

Pubmed ID

37217980

DOI: Digital Object Identifier

PMC10201023

Related Literature

Article Analysis
・Side Effects of sargramostim
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.